CellCarta has acquired the commercial rights to the antibody panels and assays from Precision Assays, a Seattle, Washington-based targeted proteomics testing solutions provider.
Source: https://www.pehub.com/arsenal-backed-cellcarta-expands-portfolio-with-new-acquisition/
Powered by WPeMatico
Comments are closed.